Skip to Content

Lucassin Approval Status

  • FDA approved: No
  • Brand name: Lucassin
  • Generic name: terlipressin
  • Dosage form: for Injection
  • Company: Mallinckrodt plc
  • Treatment for: Hepatorenal Syndrome

Lucassin (terlipressin) is a synthetic vasopressin analogue in development for the treatment of hepatorenal syndrome (HRS) Type 1.

Development Status and FDA Approval Process for Lucassin

Jul 28, 2016First Patient Enrolled in Mallinckrodt Phase 3 Terlipressin Trial
Mar 30, 2010Ikaria Acquires New Drug Application for Lucassin
Jun 12, 2009FDA Accepts Final Section of NDA Filing for Lucassin

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.